The Assessment of Movement Disorders Utilizing Live Two-Way Video
1 other identifier
observational
37
1 country
1
Brief Summary
The purpose of this project is to determine the equivalency of extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) examinations conducted via live two-way video versus live examinations completed in-person
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2011
CompletedStudy Start
First participant enrolled
November 1, 2011
CompletedFirst Posted
Study publicly available on registry
November 8, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedSeptember 21, 2016
September 1, 2016
4.6 years
October 31, 2011
September 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Abnormal Involuntary Movement Scale (AIMS) when done in-person versus via two-way video
Baseline
Modified Simpson Angus Scale (mSAS) short version when done in-person versus via two-way video
Baseline
Secondary Outcomes (1)
the correlation between the short version and full version of the Modified Simpson Angus Scale (mSAS)
Baseline
Study Arms (1)
schizophrenia
Inclusion Criteria: Inpatients and outpatients aged 18-75 years old who have been taking antipsychotics for longer than 6 months in their life time, and that have been compliant for the past week. Patients will be referred by their treating doctors if they have some evidence of movement disorder based on the physician's clinical judgment. We will also include 25% of the sample without any evidence of movement disorder. Exclusion Criteria: Patients who have medical conditions which make it difficult to perform a physical examination. Patients who are clinically too ill to consent and/or unable to cooperate with the examination procedures.
Interventions
Participants will be assessed extrapyramidal symptoms and tardive dyskinesia
Eligibility Criteria
40 patients with schizophrenia will be recruited via in- and outpatient psychiatry service of The Zucker Hillside Hospital.
You may qualify if:
- Inpatients and outpatients aged 18-75 years old who have been taking antipsychotics for longer than 6 months in their life time, and
- That have been compliant for the past week.
You may not qualify if:
- Patients who have medical conditions which make it difficult to perform a physical examination.
- Patients who are clinically too ill to consent and/or unable to cooperate with the examination procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwell Healthlead
Study Sites (1)
The Zucker Hillside Hospital
Glen Oaks, New York, 11004, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandeep Kapoor, MD
Northwell Health
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 31, 2011
First Posted
November 8, 2011
Study Start
November 1, 2011
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
September 21, 2016
Record last verified: 2016-09